The gap between her suffering and actual help felt impossibly wide.
In the quiet hours between hospital visits, tens of thousands of cancer patients in Hong Kong have found an unexpected companion in a smartphone app. SUPPORT+, developed at the University of Hong Kong, addresses a gap that has long existed in modern medicine: the space between appointments where suffering accumulates without guidance. It is a reminder that healing is not only what happens in a clinic, but what is sustained in the ordinary hours of ordinary days — and that the infrastructure of care must extend there too.
- Cancer patients on powerful medications face debilitating side effects — rashes, nausea, cognitive fog — that can quietly erode their will and ability to continue life-saving treatment.
- Traditional care pathways leave patients largely alone between appointments, with family doctors often lacking the specialist knowledge to bridge the gap.
- SUPPORT+ gives 76,000 patients a direct line to nurses who can name their symptoms, offer guidance, and escalate concerns before small crises become emergencies.
- The app has demonstrably reduced emergency visits and improved symptom management, proving that continuous, accessible support changes outcomes.
- Despite its proven impact, the platform's future now hinges on securing fresh funding — a familiar and precarious moment for healthcare innovation.
Susan Tam was seventy years old when lung cancer medication turned her nights into something unbearable. A relentless skin rash woke her at three in the morning, and every remedy she tried — moisturiser, aqueous cream, hot water — only made it worse. Her family doctor offered ointments and a referral. Her oncologist was months away. The distance between her suffering and any real help felt vast.
Then a nurse mentioned SUPPORT+. Developed by researchers at the University of Hong Kong, the app was built around a deceptively simple idea: let patients report what is actually happening to their bodies, and connect them with someone who understands cancer treatment. Within days of downloading it, Tam had answers. The itch had a name, and solutions. A nurse was suddenly reachable.
Tam's experience reflects that of 76,000 patients who have used the platform since its launch. SUPPORT+ allows users to log symptoms and side effects in real time, with nurses responding through practical advice, reassurance, or escalation to a doctor when necessary. It is telemedicine reduced to its most essential function: keeping people informed and functional in the long stretches between hospital visits where most of life unfolds.
The problem is not abstract. Cancer drugs are powerful and imprecise, producing side effects that textbooks catalogue but that a fifteen-minute appointment rarely has room to address. Unmanaged, these effects determine whether someone can work, sleep, or eat — and whether they continue taking medication that might save their lives. Hong Kong's care system, like most, was not designed for this continuity. Patients see their oncologist periodically and navigate the rest largely alone.
SUPPORT+ has shown it can change that. Patients report better symptom management and fewer emergency visits. But the app now faces a challenge common to healthcare innovation: it needs funding to survive and grow. Whether Hong Kong's health system will invest in the infrastructure that lets patients truly live while being treated remains the open question.
Susan Tam woke at three in the morning, her skin on fire. The itch was relentless, maddening—a side effect of the lung cancer medication she had started taking just weeks earlier. At seventy, she had imagined cancer would feel like sickness. Instead, it felt like her own body turning against her in the dark.
She tried everything within reach. Moisturiser. Aqueous cream, the same product she had used decades ago while working in a care home. Hot water, thinking the heat might numb the sensation. Each remedy only made it worse. When she finally saw her family doctor, he offered more ointments and a referral back to her oncologist—a distant figure she saw once every few months. The gap between her suffering and actual help felt impossibly wide.
Then a nurse mentioned an app. SUPPORT+, developed by researchers at the University of Hong Kong, was designed to do something simple but radical: let patients report what was actually happening to their bodies and get guidance from someone who understood cancer treatment. Tam downloaded it. Within days, she had answers. The itch had a name. It had solutions. A nurse was suddenly accessible, not months away.
Tam's story is one among 76,000. Since its launch, SUPPORT+ has become a lifeline for cancer patients navigating the gap between hospital visits—the space where most of life actually happens. The app allows patients to log symptoms, side effects, and concerns in real time. Nurses respond with practical advice, reassurance, or escalation to a doctor when needed. It is telemedicine stripped to its essential purpose: keeping people functional and informed while they undergo treatment.
The problem the app solves is not theoretical. Cancer medications are powerful. They work by attacking cells, but they do not discriminate perfectly. Patients experience rashes, nausea, fatigue, cognitive fog, appetite loss, and dozens of other effects that textbooks list but that doctors often have little time to address in a fifteen-minute appointment. These side effects are not minor. They determine whether someone can work, sleep, eat, or maintain any semblance of normal life. Left unmanaged, they become reasons people stop taking medication that might save their lives.
Traditional care pathways in Hong Kong, like most places, were not built for this. Patients see their oncologist periodically. Between visits, they are largely on their own. A family doctor might help, but often lacks the specific knowledge of how cancer drugs interact with the body. The result is suffering that goes unaddressed, questions that go unanswered, and patients making decisions in isolation.
SUPPORT+ fills that void. It is not a replacement for doctors. It is the infrastructure that should have existed all along—a way for patients to be heard and helped continuously, not episodically. The app has proven its value. Seventy-six thousand people have used it. The data shows it works: patients report better symptom management, fewer emergency visits, and a sense of not being abandoned between appointments.
Now the app faces a familiar problem in healthcare innovation: money. The team behind SUPPORT+ is seeking fresh funding to maintain and expand the platform. Without it, the app that has become essential to tens of thousands of patients could stall. The question is not whether the need exists—Tam's sleepless nights proved that long ago. The question is whether Hong Kong's healthcare system will invest in the infrastructure that lets patients actually live while they are being treated.
Notable Quotes
I did not feel unwell or sick from the cancer at all, until I started taking the cancer drugs.— Susan Tam, cancer patient
The Hearth Conversation Another angle on the story
Why does an app matter here? Couldn't a nurse hotline do the same thing?
A hotline requires someone to pick up the phone at the right moment, explain your problem to a stranger, wait for a callback. An app lets you log a symptom at three in the morning when you can't sleep, and a nurse sees it when she starts her shift. It's asynchronous. It's there when you need it, not when the system has capacity.
But isn't this just convenience? Are we talking about life-or-death situations?
Sometimes, yes. But mostly it's about whether someone keeps taking medication that might save their life. If your skin is burning and no one helps, you stop the pills. Then the cancer progresses. That's the stakes.
What makes this different from what hospitals already offer?
Hospitals see you every few months. This is continuous. And it's designed specifically for the gap—the 90 days between appointments when you're alone with side effects and no one to ask.
Why is funding the problem if 76,000 people are already using it?
Because it's running on research money and goodwill. Scaling it, maintaining servers, paying nurses—that costs real money. And healthcare systems are slow to fund things that work but don't fit the traditional billing model.
What happens if the funding doesn't come through?
The app goes dormant. Those 76,000 people lose access. And the next patient like Susan Tam goes back to waking up at three in the morning with no one to call.